ZIRCONIUM ZR-89 CREFMIRLIMAB BERDOXAM
UNII J6AJI0OZ1O

Substance Identification & Data

This profile provides standardized clinical and technical data for Zirconium Zr-89 Crefmirlimab Berdoxam, uniquely identified by the FDA Unique Ingredient Identifier (UNII) J6AJI0OZ1O.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2377668-38-5 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

J6AJI0OZ1O

CAS Registry Number

2377668-38-5

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

ZIRCONIUM ZR-89 CREFMIRLIMAB BERDOXAM

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C137822

National Cancer Institute reference terminology for clinical and research data.

INN ID

12138

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

JK-118

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Zirconium Zr-89 Crefmirlimab Berdoxam. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

ZIRCONIUM (89ZR) CREFMIRLIMAB BERDOXAM

ZIRCONIUM ZR-89 CREFMIRLIMAB BERDOXAM

Common Names & Synonyms

IAB22M2C (ANTIBODY FRAGMENT AGAINST THE HUMAN CD8-ANTIGEN ON CD8-POSITIVE T-CELLS, CONJUGATED TO THE CHELATOR DESFERRIOXAMINE (DF) AND LABELED WITH THE RADIOISOTOPE ZIRCONIUM ZR-89)

IMMUNOGLOBULIN, ANTI-(HUMAN CD8A ANTIGEN) (HUMAN-MUS MUSCULUS MONOCLONAL IAB22M2C .KAPPA.-CHAIN V-J REGION) FUSION PROTEIN WITH PEPTIDE LINKER (GSTSGGGSGGGSGGGGSS) FUSION PROTEIN WITH IMMUNOGLOBULIN ANTI-(HUMAN CD8A ANTIGEN) (HUMAN-MUS MUSCULUS MONOCLONAL IAB22M2C HEAVY CHAIN V-D-J REGION) FUSION PROTEIN WITH IMMUNOGLOBULIN G1 (SYNTHETIC .GAMMA.1-CHAIN HINGE REGION) FUSION PROTEIN WITH PEPTIDE LINKER (GGGSSGGGSG) FUSION PROTEIN WITH IMMUNOGLOBULIN G1 (DE-C-TERMINAL LYSINE) (HUMAN .GAMMA.1-CHAIN CH3 REGION), DIMER, N6-(((4-((8,19,30-TRI(HYDROXY-.KAPPA.O)-9,20,31-TRI(OXO-.KAPPA.O)-12,23-DIOXO-1-THIOXO-2,8,13,19,24,30-HEXAAZADOTRIACONT-1-YL)AMINO)PHENYL)AMINO)THIOXOMETHYL)-L-LYSINE, COMPLEX WITH ZIRCONIUM-89ZR

ZIRCONIUM (89ZR) CREFMIRLIMAB BERDOXAM [INN]

ZIRCONIUM (89ZR) CREFMIRLIMAB BERDOXAM [WHO-DD]

ZIRCONIUM ZR 89 CREFMIRLIMAB BERDOXAM [USAN]

ZIRCONIUM ZR 89-DF-IAB22M2C

ZIRCONIUM ZR-89-DESFERRIOXAMINE-IAB22M2C